IL106369A0 - A specific 1,4-dihydropyridine-3,5-dicarboxylic acid ester,its preparation and pharmaceutical compositions containing it - Google Patents

A specific 1,4-dihydropyridine-3,5-dicarboxylic acid ester,its preparation and pharmaceutical compositions containing it

Info

Publication number
IL106369A0
IL106369A0 IL106369A IL10636993A IL106369A0 IL 106369 A0 IL106369 A0 IL 106369A0 IL 106369 A IL106369 A IL 106369A IL 10636993 A IL10636993 A IL 10636993A IL 106369 A0 IL106369 A0 IL 106369A0
Authority
IL
Israel
Prior art keywords
dihydropyridine
preparation
specific
acid ester
pharmaceutical compositions
Prior art date
Application number
IL106369A
Other languages
English (en)
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of IL106369A0 publication Critical patent/IL106369A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cardiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyridine Compounds (AREA)
IL106369A 1992-07-20 1993-07-16 A specific 1,4-dihydropyridine-3,5-dicarboxylic acid ester,its preparation and pharmaceutical compositions containing it IL106369A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4223867A DE4223867A1 (de) 1992-07-20 1992-07-20 Spezieller 1,4-Dihydropyridin-3,5-dicarbonsäureester, Verfahren zu seiner Herstellung und seine pharmazeutische Verwendung

Publications (1)

Publication Number Publication Date
IL106369A0 true IL106369A0 (en) 1993-11-15

Family

ID=6463655

Family Applications (1)

Application Number Title Priority Date Filing Date
IL106369A IL106369A0 (en) 1992-07-20 1993-07-16 A specific 1,4-dihydropyridine-3,5-dicarboxylic acid ester,its preparation and pharmaceutical compositions containing it

Country Status (16)

Country Link
US (1) US5559139A (xx)
EP (1) EP0581079A1 (xx)
JP (1) JPH06179654A (xx)
KR (1) KR940002223A (xx)
CN (1) CN1085548A (xx)
AU (1) AU4164693A (xx)
CA (1) CA2100707A1 (xx)
CZ (1) CZ141593A3 (xx)
DE (1) DE4223867A1 (xx)
FI (1) FI933255A (xx)
HU (1) HU9302077D0 (xx)
IL (1) IL106369A0 (xx)
MX (1) MX9304119A (xx)
PL (1) PL299713A1 (xx)
SK (1) SK76293A3 (xx)
ZA (1) ZA935191B (xx)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103044316A (zh) * 2013-01-23 2013-04-17 石家庄学院 一种以咪唑离子液体为催化剂制备1,4-二氢吡啶的方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3883543A (en) * 1969-05-10 1975-05-13 Bayer Ag N-alkyl-1,4-dihydropyridines
DE1923990C3 (de) * 1969-05-10 1978-11-23 Bayer Ag Verfahren zur Herstellung von N-substituierten M-Dihydropyridin-S.S-dicarbonsäureestern
DE2210667A1 (de) * 1972-03-06 1973-09-20 Bayer Ag Kondensiert aromatisch substituierte 1,4-dihydropyridine, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
US3956341A (en) * 1974-02-21 1976-05-11 Smithkline Corporation 1,3,5-Tricarbo-1,4-dihydropyridines
US4975440A (en) * 1984-09-28 1990-12-04 Byk Gulden Lomberg Chemische Fabrik Gmbh Optically-active 1,4-dihydropyridine
US4780538A (en) * 1986-02-12 1988-10-25 Merck & Co., Inc. Process for 1,4-dihydropyridine compounds using a titanamine catalyst
DE4011695A1 (de) * 1990-04-11 1991-10-17 Bayer Ag Verwendung von n-alkylierten 1,4-dihydropyridindicarbonsaeureestern als arzneimittel, neue verbindungen und verfahren zu ihrer herstellung
DE4200714A1 (de) * 1992-01-14 1993-07-15 Bayer Ag Spezieller 1,4-dihydropyridin-3,5-dicarbonsaeureester, verfahren zu seiner herstellung und seine pharmazeutische verwendung

Also Published As

Publication number Publication date
KR940002223A (ko) 1994-02-16
ZA935191B (en) 1994-03-02
FI933255A0 (fi) 1993-07-16
JPH06179654A (ja) 1994-06-28
HU9302077D0 (en) 1993-10-28
EP0581079A1 (de) 1994-02-02
CN1085548A (zh) 1994-04-20
CA2100707A1 (en) 1994-01-21
CZ141593A3 (en) 1994-03-16
AU4164693A (en) 1994-01-27
FI933255A (fi) 1994-01-21
MX9304119A (es) 1994-02-28
DE4223867A1 (de) 1994-01-27
US5559139A (en) 1996-09-24
PL299713A1 (en) 1994-03-21
SK76293A3 (en) 1994-07-06

Similar Documents

Publication Publication Date Title
IL105035A0 (en) Substituted pipecolinic acid derivatives,their preparation and pharmaceutical compositions containing them
NZ250762A (en) Five-membered-heterocyclic carboxylic acid derivatives and pharmaceutical compositions
IL103932A (en) Fatty acid and pharmaceutical compositions containing them
NZ212895A (en) 1,4-dihydropyridine derivatives and pharmaceutical compositions
IL107956A0 (en) Carboxylic acid derivatives, their preparation and pharmaceutical compositions containing them
IL105700A0 (en) Pharmaceutical compositions containing a retinoic acid or a salt or ester thereof and a vitamin d derivative
NZ213461A (en) 1,4-dihyrdropyridine-3,5-dicarboxylic acid derivatives and pharmaceutical compositions
KE3593A (en) A 1,4-dihydropyridine derivative its preparation and pharmaceutical compositions containing it
NZ231353A (en) Pharmaceutical compositions comprising 3,5-dihydroxy-7-(1-acyloxyhexahydronaphth-8-yl)-heptanoic acid and lactone derivatives
IL101771A0 (en) Carboxylic acid derivatives,their manufacture and pharmaceutical compositions containing them
IL104357A0 (en) Specific 1,4-dihydropyridine-3,5-dicarboxylic acid ester,its preparation and pharmaceutical compositions containing it
IL84724A0 (en) Substituted aminomethyl-5,6,7,8-tetrahydronaphthyloxyacetic acids and esters and amides thereof,their preparation and pharmaceutical compositions containing them
IL110078A0 (en) N-substituted azaheterocyclic carboxylic acids and esters thereof, their preparation and pharmaceutical compositions containing them
IL105391A0 (en) 1,2,4-benzothiadiazine-3-carboxylic acid derivatives,their preparation and pharmaceutical compositions containing them
IL108930A0 (en) 2,3-Diamino-3- hydroxycarboxylic acid derivatives, their preparation and pharmaceutical compositions containing them
IL106369A0 (en) A specific 1,4-dihydropyridine-3,5-dicarboxylic acid ester,its preparation and pharmaceutical compositions containing it
IL108920A0 (en) Acyloxyhexanoic acid derivatives and pharmaceutical compositions containing them
NZ216555A (en) 1,4-dihydropyridine derivatives and pharmaceutical compositions
IL115030A0 (en) Use of 1,4-dihydropyridine - 3,5-dicarboxylic acid esters as medicaments
NZ215083A (en) 1,4-dihydropyridine derivatives and pharmaceutical compositions
NZ238848A (en) Sulphur-substituted mevinic acid compounds and pharmaceutical compositions
ZA876716B (en) Pharmaceutical composition containing a 1,4-dihydropyridine derivative and an acylated 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid
AU3893289A (en) Pyrrolidinone and piperidinone compounds and pharmaceutical compositions containing same
IL94937A0 (en) Pharmaceutical compositions containing acrylic acid derivatives
IL101998A0 (en) 6-o-alkylelsamicin a derivatives and pharmaceutical compositions containing them